1–2 of 2 results for Alay S. Banker
Results of Perimetry at Age of 10 Years in Severe ROP Eyes Receiving Laser or Anti-VEGF Treatment as Primary Monotherapy
Alay S. Banker, MD
Annual Meeting Talks
2020
New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases
2018